COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week

The trial is conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are currently undergoing trials.

Original source: https://health.economictimes.indiatimes.com/news/pharma/84676739?utm_source=RSS&utm_medium=ETRSS

Related Posts